Clinical Drug Development and Therapeutics

Drug Development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. Drug design often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the biomolecular target with which they interact and therefore will bind to it. The drug is the application of known drugs and compounds to treat new indications. 

  • Pre-clinical development
  • Personalized, stratified and translational medicine
  • Drug re-positioning
  • Generic drug
  • Evidence based practice
  • Clinical impact of drug formulations
  • Developing of novel medication safety clinical programs
  • Rational therapeutics

Related Conference of Clinical Drug Development and Therapeutics

Clinical Drug Development and Therapeutics Conference Speakers